TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Digestive Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Digestive Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Digestive Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Digestive Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Digestive Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Digestive Drugs industry

EP3000874Sex Sorted Sperm Demonstrating A Dose Response And Methods Of Producing Sex Sorted Sperm Demonstrating A Dose ResponseINGURANJun 18, 2025ABS
EP3854403Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
EP3487881Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025HAMPTON KNOWLES
EP3487881Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 20, 2025NEUEFEIND
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICAL INDUSTRIES
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 6, 2025SANDOZ
EP3923943Genotype And Dose-Dependent Response To An Asbti In Patients With Bile Salt Export Pump DeficiencyMIRUM PHARMACEUTICALSApr 30, 2025GENERICS UK
EP3881861Dosage Regimes For The Administration Of Glucagon-Like-Peptide-2 (Glp-2) AnaloguesZEALAND PHARMAApr 29, 2025IRONWOOD PHARMACEUTICALS
EP3175863Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALApr 10, 2025ASCENDIS PHARMA
EP3932410Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025SOCIETE DES PRODUITS NESTLE

To stay ahead in the competitive Digestive Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Digestive Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
EP3725778Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
EP2228064Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
EP2981271Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM8
EP2350096Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
EP3487881Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTIS7
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
EP3889181Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7